Login / Signup

Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis.

Thomas J MoorePhillip W WirtzJill N CurranG Caleb Alexander
Published in: BMJ open (2023)
A large proportion of adults using Schedule II stimulants are simultaneously exposed to one or more other CNS-active drugs, many with tolerance, withdrawal effects or potential for non-medical use. There are no approved indications and limited clinical trial testing of these multi-drug combinations, and discontinuation may be challenging.
Keyphrases
  • clinical trial
  • healthcare
  • drug induced
  • adverse drug
  • emergency department
  • open label
  • study protocol
  • blood brain barrier
  • double blind
  • young adults
  • mesenchymal stem cells
  • climate change
  • childhood cancer